Cognizant Technology Solutions Corporation

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 972 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• HOLDINGS SIDE IS EMPTY, and that is a checked finding, not an unexamined gap. Searched the Q2 FY2026 10-Q (filed 29 Jul 2026, period 30 Jun 2026, the most recent SEC filing, fresher than the FY2025 10-K filed 12 Feb 2026) for 'equity investment', 'non-marketable' (0 hits), 'unrealized gain', 'investment in', 'joint venture' (0 hits) and 'minority interest' (0 hits). Also searched the FY2025 10-K (filed 12 Feb 2026, period 31 Dec 2025) for the same terms plus 'cost method'. Also read Exhibit 21 (list of subsidiaries) from that 10-K: it is a bare name list with no ownership-percentage column, a genuine negative rather than evidence of looking in the wrong place.
• Cognizant does carry an EQUITY-METHOD INVESTMENT, but it cannot be turned into a holdings row because the investee is never named in any filing found. The FY2025 10-K states (Note 1, Summary of Significant Accounting Policies): 'As of December 31, 2025 and 2024, we had an equity method investment of $104 million and $84 million, respectively, in the technology sector.' The Q2 2026 10-Q confirms the position is still live and reporting losses: 'Income (loss) from equity method investments' of $(8) million for Q2 2026 and $(5) million for H1 2026. This is a single, named-category (not a combined multi-investee bucket per the filing's own singular wording, 'an equity method investment'), but the counterparty company's name does not appear anywhere in the 10-K or 10-Q text searched, so no target_name can be attached and no row was created. The $104 million figure and the investee's absence from disclosure are recorded here per the brief's instruction to note what a combined/unnamed balance does NOT tell you.
• A separate, smaller item, an 'Equity investment security' carried at $12 million (Level 1, Dec 2025) / $11 million (Q2 2026), is described in both filings as 'a U.S. dollar denominated investment in a fixed income mutual fund' valued at published daily NAV. This is a marketable fund holding, not a strategic equity stake, and is excluded per the brief's exclusion of money-market/treasury-style holdings.
• FOUNDER/INSIDER CHECK (per the brief's instruction for companies with founder history): the 17 Apr 2026 DEF 14A states plainly, 'Each of our directors and NEOs owns less than 1% of the total outstanding shares of our common stock. The current directors and executive officers as a group do not own more than 1% of the total outstanding shares.' No individual director or officer, including CEO Ravi Kumar S (in the role since Jan 2023), is separately disclosed as a 5% holder or as holding a materially large stake. This is a genuine, sourced negative: Cognizant's founder-era concentration (Kumar Mahadeva and other early holders) has been diluted away and does not appear as a Schedule 13D/G filer or proxy 5%-owner in the current filing.
• The DEF 14A's OWN 5% beneficial-owner table is thin and partly stale: it lists only BlackRock (sourced to a Schedule 13G/A filed 24 Apr 2025) and State Street (sourced to a Schedule 13G filed 17 Oct 2024), both well over a year old at the time of this research. It also carries a footnote that on 26 March 2026 Vanguard reported an internal realignment under which it no longer has, or is deemed to have, beneficial ownership over shares held by various subsidiaries/business divisions, so Vanguard drops out of the proxy's 5%-table entirely even though the fresh Q2 2026 13F family sweep shows it as the largest holder at 13.82%. Per the brief, the fresh Q2 2026 13F-HR figures were used throughout instead of these stale 13G citations; the stale figures are kept in each row's own method_note as the reconciliation.
• SELF-GATE, computed from this final file exactly as the chart does: 12 register rows, sum of shares = 256,968,000, shares_outstanding = 450,444,209, giving 57.05%. This is above the brief's approximate 55% ceiling, so it was investigated rather than shipped blind. No double-counted holder was found: all three Capital Group CIKs were checked individually (only one, Capital Research Global Investors, holds CTSH; the other two returned zero rows) and no other family or entity appears twice across the 12 rows. Every one of the 12 rows independently implies the same $38.73-$38.75 per-share price on 30 Jun 2026 (value/shares), which rules out a units/thousands error on any row. Cross-check against this project's own 31-Mar-2026 snapshot (data/registers/CTSH.json): the same 12 institutions there sum to approximately 256.25 million shares against the same-order-of-magnitude denominator, an independent prior-quarter confirmation that this concentration is real rather than an artifact introduced by this file. External corroboration: stockanalysis.com's statistics page for CTSH (fetched 19 Aug 2026) reports aggregate institutional ownership of 115.98% of shares outstanding across ALL 13F filers (not just the top 12 used here), a well-known industry artifact of securities lending and shared-voting/dispositive-power double-reporting across large-cap 13F filers. A top-12 subset landing at 57% is consistent with, not anomalous against, that market-wide baseline.
• market_cap_usd of $26.03 billion (as of 18 Aug 2026, stockanalysis.com) cross-checks against shares_outstanding: 450,444,209 x $57.78 (the share price stated on the same page) = approximately $26.03 billion, an internal consistency check that passed.